Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
- Status
- RECRUITING
- Phase
- PHASE2
Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Assess the Relative Bioavailability of 5 mg Mavacamten Opened Capsule Administered Via Nasogastric Tube Compared to Intact Oral 5 mg Mavacamten in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study
- Status
- WITHDRAWN
- Phase
- PHASE4
A Lactation Study in Women Receiving Treatment With Ozanimod
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study to Assess Health-Related Quality of Life in Patients With Hypertrophic Cardiomyopathy in Japan
- Status
- COMPLETED
- Phase
- N/A
Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate Treatment With Nivolumab Alone and Nivolumab Combined With Ipilimumab in Children With Melanoma
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan
- Status
- COMPLETED
- Phase
- N/A
Incidence of Hyperpigmentation in Black Patients With Multiple Myeloma Treated With Immunomodulatory Drugs
- Status
- COMPLETED
- Phase
- N/A
Real-World Outcomes in Relapsed/Refractory Multiple Myeloma Patients Treated, or Eligible for Treatment, With Idecabtagene Vicleucel
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participants
- Status
- TERMINATED
- Phase
- PHASE1